RNA protein kinase SNP at −226 C<T is a biomarker for the clearance of HCV among Egyptian patients

References

• Afify M, Hamza AH, Alomari RA. (2017). Correlation Between Serum Cytokines, Interferons, and Liver Functions in Hepatitis C Virus Patients. J Interferon Cytokine Res, 37(1), 32–38. doi:10.1089/jir.2016.0044.
   Web of Science ®Google Scholar
• Afzal, S., M. Idrees, M. Akram, et al. (2010). Mutations in the E2-PePHD region of hepatitis C virus genotype-3a and correlation with response to interferon and ribavirin combination therapy in Pakistani patients. Virol J. 7(1), 377. doi: 10.1186/1743-422X-7-377.
   Web of Science ®Google Scholar
• Antonelli A, Pistello M. (2017). New Therapies, Markers and Therapeutic Targets in HCV Chronic Infection and HCV Extrahepatic Manifestations. Curr Drug Targets, 18(7), 752–755. doi:10.2174/1389450116666151102095708.
   Web of Science ®Google Scholar
• Asahina, Y., N. Izumi, N. Umeda, et al. (2007). Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha‐2b and ribavirin. J Viral Hepat. 14, 396–403. doi: 10.1111/j.1365-2893.2006.00803.x.
   PubMed Web of Science ®Google Scholar
• Berzsenyi, M., S. Roberts, S. Preiss, et al. (2011). Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF‐α in HCV & HCV/HIV infection. J Viral Hepat. 18(12), 852–860. doi: 10.1111/j.1365-2893.2010.01390.x.
   Web of Science ®Google Scholar
• Borden, E.C., G.C. Sen, G. Uze, et al. (2007). Interferons at age 50: past. Current Future Impact Biomedicine Nature Reviews Drug Discovery. 6(12), 975–990. doi: 10.1038/nrd2422.
   Google Scholar
• Chu W-M. (2013). Tumor necrosis factor. Cancer Lett, 328, 222–225. doi:10.1016/j.canlet.2012.10.014.
   PubMed Web of Science ®Google Scholar
• Clemens, M., K. Laing, I. Jeffrey, et al. (1994). Regulation of the interferon-inducible eIF-2α protein kinase by small RNAs. Biochimie, 76(8), 770–778.
   Web of Science ®Google Scholar
• Dabo S, Meurs EF. (2012). dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection. Viruses, 4(11), 2598–2635. doi:10.3390/v4112598.
   Web of Science ®Google Scholar
• Das, S., S. V. Ward, R. S. Tacke, et al. (2006). Activation of the RNA-dependent protein kinase PKR promoter in the absence of interferon is dependent upon Sp proteins. Journal of Biological Chemistry. 281(6), 3244–3253. doi: 10.1074/jbc.M510612200.
   Web of Science ®Google Scholar
• De Rueda, P.M., J. Casado, R. Paton, et al. (2008). Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of hepatitis C virus genotype 1 and their relationships to pegylated interferon-ribavirin treatment responses. J Virol. 82, 6644–6653. doi: 10.1128/JVI.02231-07.
   PubMed Web of Science ®Google Scholar
• El Din, N.G.B., S. Farouk, R. El-Shenawy, et al. (2016). Tumor necrosis factor-α-G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients. World Journal of Gastroenterology. 22(34), 7767. doi: 10.3748/wjg.v22.i37.8314.
   Web of Science ®Google Scholar
• Gaudy, C., M. Lambelé, A. Moreau, et al. (2005). Mutations within the hepatitis C virus genotype 1b E2-PePHD domain do not correlate with treatment outcome. J Clin Microbiol. 43(2), 750–754. doi: 10.1128/JCM.43.2.750-754.2005.
   Web of Science ®Google Scholar
• Haibo Sun YP, Ruihong Wu, Juan Lv, et al. (2015). CD24 Ala57Val polymorphismis associated with spontaneous viral clearance in the HCV-infected Chinese population. Liver Int, 35, 786–794. doi:10.1111/liv.12506.
   PubMed Web of Science ®Google Scholar
• Hajarizadeh B, Grebely J, Dore GJ. (2013). Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol, 10, 553–562. doi:10.1038/nrgastro.2013.107.
   PubMed Web of Science ®Google Scholar
• Kamal SM, Nasser IA. (2008). Hepatitis C genotype 4: what we know and what we don’t yet know. Hepatology, 47(4), 1371–1383. doi:10.1002/hep.22127.
   Web of Science ®Google Scholar
• Knapp, S., L. Yee, A. Frodsham, et al. (2003). Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun. 4, 411–419. doi: 10.1038/sj.gene.6363984.
   PubMed Web of Science ®Google Scholar
• Kuhen KL, Samuel CE. (1997). Isolation of the Interferon-Inducible RNA-Dependent Protein KinasePkrPromoter and Identification of a Novel DNA Element within the 5′-Flanking Region of Human and MousePkrGenes. Virology, 227, 119–130. doi: 10.1006/viro.1996.8306.
   PubMed Web of Science ®Google Scholar
• Larijani, M.S., L. N. Rad, M. Nikbin, et al. (2016). Impact of TGF-β1 Gene Polymorphism (rs1800469) on Treatment Response to Pegylated Interferon/Ribavirin in Iranian Patients with Hepatitis C. Clin Lab, 62, 609–614. 10.7754/Clin.Lab.2015.150807
   PubMed Web of Science ®Google Scholar
• LU, Y., M. WAMBACH, M. G. KATZE, R. M. KRUG. (1995). Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the eIF-2 translation initiation factor. Virology, 214, 222–228. 10.1006/viro.1995.9937
   PubMed Web of Science ®Google Scholar
• Manche, L., S. R. Green, C. Schmedt and M. B. Mathews (1992). Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol Cell Biol, 12, 5238–5248. 10.1128/MCB.12.11.5238
   PubMed Web of Science ®Google Scholar
• Martin‐Blondel, G., A. Gales, J. Bernad, L. Cuzin, et al. (2009). Low interleukin‐10 production by monocytes of patients with a self‐limiting hepatitis C virus infection. J Viral Hepat. 16, 485–491. doi: 10.1111/j.1365-2893.2009.01094.x.
   PubMed Web of Science ®Google Scholar
• Núñez, C., D. Alecsandru, J. Varadé, et al. (2006). Interleukin-10 haplotypes in Celiac Disease in the Spanish population. BMC Med Genet. 7(1), 32. doi: 10.1186/1471-2350-7-32.
   Web of Science ®Google Scholar
• Ohno, O., M. Mizokami, R.R. Wu, et al. (1997). New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol, 35(1), 201–207.
   Web of Science ®Google Scholar
• Oliveira, K.G., F. M. Malta, C. Ana, et al. (2016). Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3. Med Microbiol Immunol. 205(2), . doi: 10.1007/s00430-015-0431-0.
   Web of Science ®Google Scholar
• Pathak V, Schindler D, Hershey J. (1988). Generation of a mutant form of protein synthesis initiation factor eIF-2 lacking the site of phosphorylation by eIF-2 kinases. Mol Cell Biol, 8(2), 993–995. doi:10.1128/MCB.8.2.993
   Web of Science ®Google Scholar
• Samuel CE. (1979). Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc Natl Acad Sci, 76, 600–604. doi:10.1073/pnas.76(2): 600-604.
   PubMed Web of Science ®Google Scholar
• Szabó, E., G. Lotz, C. Páska, et al. (2003). Viral hepatitis: new data on hepatitis C infection. Pathol Oncol Res. 9(4), 215–221. doi: 10.1007/BF02893380.
   Web of Science ®Google Scholar
• Tan, H., Q. He, R. Li, et al. (2016). Trillin reduces liver chronic inflammation and fibrosis in carbon tetrachloride (CCl4) induced liver injury in mice. Immunol Invest. 45(5), 371–382. doi: 10.3109/08820139.2015.1137935.
   Web of Science ®Google Scholar
• Thomson, E.C., V. M. Fleming, J. Main, et al. (2010). Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut. p. gut. 2010.217166.
   Google Scholar
• Yee, L.J., J. Tang, A. W. Gibson, et al. (2001). Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology. 33(3), 708–712. doi: 10.1053/jhep.2001.22347.
   Web of Science ®Google Scholar
• Yu, S.H., K. Nagayama, N. Enomoto, et al. (2000). Intrahepatic mRNA expression of interferon‐inducible antiviral genes in liver diseases: dsRNA‐dependent protein kinase overexpression and RNase L inhibitor suppression in chronic hepatitis C. Hepatology. 32(5), 1089–1095. doi: 10.1053/jhep.2000.19287.
   Web of Science ®Google Scholar
• Zaltron, S., A. Spinetti, L. Biasi, et al. (2012). Chronic HCV infection: epidemiological and clinical relevance. BMC Infect Dis. 12, S2. doi: 10.1186/1471-2334-12-166.
   PubMed Web of Science ®Google Scholar
• Zhang D, Feng G. (2014). Effects of hepatitis C virus core protein on activity of double-stranded RNA-dependent protein kinase. Zhonghua Gan Zang Bing Za Zhi= Zhonghua Ganzangbing Zazhi= Chinese Journal of Hepatology, 22(8), 590–593.
   Google Scholar